Irhythm Technologies Stock Performance
| IRTC Stock | USD 104.49 0.15 0.14% |
On a scale of 0 to 100, IRhythm Technologies holds a performance score of 8. The company retains a Market Volatility (i.e., Beta) of 0.43, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, IRhythm Technologies' returns are expected to increase less than the market. However, during the bear market, the loss of holding IRhythm Technologies is expected to be smaller as well. Please check IRhythm Technologies' semi variance, day typical price, and the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether IRhythm Technologies' current trending patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in iRhythm Technologies are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, IRhythm Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.14 | Five Day Return 2.64 | Year To Date Return 16.83 | Ten Year Return 301.11 | All Time Return 301.11 |
1 | Acquisition by Chad Patterson of 10674 shares of IRhythm Technologies subject to Rule 16b-3 | 01/03/2025 |
2 | Is It Too Late To Consider Buying iRhythm Technologies, Inc. | 01/31/2025 |
3 | iRhythm Technologies Announces Fourth Quarter andFull Year 2024 | 02/20/2025 |
4 | iRhythm targets 675M-685M revenue for 2025 driven by Zio adoption and international expansion | 02/21/2025 |
5 | iRhythm Technologies Upgraded to Hold at StockNews.com | 02/25/2025 |
6 | Disposition of 2341 shares by Daniel Wilson of IRhythm Technologies at 108.77 subject to Rule 16b-3 | 03/03/2025 |
7 | Acquisition by Chad Patterson of 10742 shares of IRhythm Technologies subject to Rule 16b-3 | 03/06/2025 |
8 | Patient Monitoring Stocks Q4 Results Benchmarking ResMed | 03/11/2025 |
9 | Tempus AI Surges 40 percent YTD Are New Strategic Deals a Buy Signal | 03/17/2025 |
| Begin Period Cash Flow | 36.2 M |
IRhythm |
IRhythm Technologies Relative Risk vs. Return Landscape
If you would invest 8,937 in iRhythm Technologies on December 24, 2024 and sell it today you would earn a total of 1,512 from holding iRhythm Technologies or generate 16.92% return on investment over 90 days. iRhythm Technologies is currently generating 0.2932% in daily expected returns and assumes 2.5702% risk (volatility on return distribution) over the 90 days horizon. In different words, 22% of stocks are less volatile than IRhythm, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
IRhythm Technologies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for IRhythm Technologies' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as iRhythm Technologies, and traders can use it to determine the average amount a IRhythm Technologies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1141
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IRTC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.57 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average IRhythm Technologies is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IRhythm Technologies by adding it to a well-diversified portfolio.
IRhythm Technologies Fundamentals Growth
IRhythm Stock prices reflect investors' perceptions of the future prospects and financial health of IRhythm Technologies, and IRhythm Technologies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IRhythm Stock performance.
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.0654 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 3.48 B | ||||
| Shares Outstanding | 31.41 M | ||||
| Price To Earning | (36.08) X | ||||
| Price To Book | 36.10 X | ||||
| Price To Sales | 5.55 X | ||||
| Revenue | 591.84 M | ||||
| Gross Profit | 407.53 M | ||||
| EBITDA | (74.13 M) | ||||
| Net Income | (113.29 M) | ||||
| Cash And Equivalents | 204.49 M | ||||
| Cash Per Share | 6.81 X | ||||
| Total Debt | 736.91 M | ||||
| Debt To Equity | 0.54 % | ||||
| Current Ratio | 4.05 X | ||||
| Book Value Per Share | 2.90 X | ||||
| Cash Flow From Operations | 3.39 M | ||||
| Earnings Per Share | (3.63) X | ||||
| Market Capitalization | 3.28 B | ||||
| Total Asset | 931.45 M | ||||
| Retained Earnings | (758.89 M) | ||||
| Working Capital | 534.9 M | ||||
| Current Asset | 54.91 M | ||||
| Current Liabilities | 11.97 M | ||||
About IRhythm Technologies Performance
By analyzing IRhythm Technologies' fundamental ratios, stakeholders can gain valuable insights into IRhythm Technologies' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if IRhythm Technologies has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if IRhythm Technologies has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 27.80 | 23.05 | |
| Return On Tangible Assets | (0.12) | (0.13) | |
| Return On Capital Employed | (0.14) | (0.15) | |
| Return On Assets | (0.12) | (0.13) | |
| Return On Equity | (1.25) | (1.18) |
Things to note about iRhythm Technologies performance evaluation
Checking the ongoing alerts about IRhythm Technologies for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for iRhythm Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 591.84 M. Net Loss for the year was (113.29 M) with profit before overhead, payroll, taxes, and interest of 407.53 M. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: Tempus AI Surges 40 percent YTD Are New Strategic Deals a Buy Signal |
- Analyzing IRhythm Technologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IRhythm Technologies' stock is overvalued or undervalued compared to its peers.
- Examining IRhythm Technologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating IRhythm Technologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of IRhythm Technologies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of IRhythm Technologies' stock. These opinions can provide insight into IRhythm Technologies' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for IRhythm Stock analysis
When running IRhythm Technologies' price analysis, check to measure IRhythm Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRhythm Technologies is operating at the current time. Most of IRhythm Technologies' value examination focuses on studying past and present price action to predict the probability of IRhythm Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRhythm Technologies' price. Additionally, you may evaluate how the addition of IRhythm Technologies to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |